Search clinical trials for: Buparlisib matching Placebo
Total 54232 results
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Novartis PharmaceuticalsTerminatedHead and Neck Squamous Cell CarcinomaGermany, United Kingdom, United States, Spain, Italy, Canada, Poland, Russian Federation, Switzerland, Thailand, Korea, Republic of, Hungary, Ireland, Australia, Taiwan, France, India, Japan
-
Novartis PharmaceuticalsCompletedRenal ImpairmentCzechia, Germany, Romania, Bulgaria
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
Canadian Cancer Trials GroupNovartisCompletedChronic Lymphocytic LeukemiaCanada
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
University Hospital TuebingenUniversity Hospital DresdenUnknownMalignant Melanoma | MetastasesGermany
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Nowarta Biopharma IncCompletedPlantar WartsUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Novartis PharmaceuticalsCompletedLymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Won KimNovartisTerminated
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Dana-Farber Cancer InstituteCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular LymphomaUnited States, Belgium, Germany, France, Italy, Korea, Republic of, Spain, Turkey
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedLymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System LymphomaUnited States
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Resverlogix CorpNot yet recruiting
-
Syneos HealthShanghai Novamab Biopharmaceuticals Co. Ltd.Terminated
-
China Medical University HospitalCompleted
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Huabo Biopharm Co., Ltd.Completed
-
SCRI Development Innovations, LLCNovartisCompletedNon Small Cell Lung CancerUnited States
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
Patrick Y. Wen, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedAsthma; Allergic RhinitisChina
-
Anji PharmaCovanceCompletedFunctional ConstipationChina, United States
-
YSOPIA BioscienceCompleted
-
Intercept PharmaceuticalsNot yet recruiting
-
New Beta Innovation LimitedTerminated
-
SIMR (Australia) Biotech Pty Ltd.CompletedHealthy VolunteersAustralia
-
BayerCompletedHealthy Volunteers | Contrast Enhancement in Magnetic Resonance ImagingJapan
-
BayerCompleted
-
Astellas Pharma Global Development, Inc.Completed
-
Kyowa Hakko Kirin Pharma, Inc.CompletedAlzheimer's DiseaseBelgium, Finland, Netherlands, Serbia, Sweden
-
Merck Sharp & Dohme LLCTerminated
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
Immune DesignTerminatedSarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic SarcomaUnited States, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Celldex TherapeuticsRecruitingEosinophilic EsophagitisUnited States, Spain, United Kingdom, Canada, Italy, Poland, Australia, Germany
-
Novartis PharmaceuticalsActive, not recruitingAlzheimer Disease | Mild Cognitive ImpairmentFrance, Spain, Sweden, Finland
-
Jiangsu HengRui Medicine Co., Ltd.Withdrawn
-
BayerCompletedOveractive Bladder | Diabetic Neuropathic Pain | Endometriosis Related Pain | Refractory or Unexplained Chronic CoughJapan
-
Regeneron PharmaceuticalsCompletedFibrodysplasia Ossificans ProgressivaUnited States, Spain, Canada, France, Poland, Italy, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsTerminatedPain | Osteoarthritis of the KneeUnited States, Georgia, Moldova, Republic of, Poland, Ukraine
-
Genentech, Inc.Completed
-
AstraZenecaParexelTerminated
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Icahn School of Medicine at Mount SinaiSanofi; Regeneron Pharmaceuticals; Rockefeller UniversityCompletedTreatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)Alopecia AreataUnited States